Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The cutaneous porphyrias.

H W Lim1, J L Cohen

  • 1Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA.

Seminars in Cutaneous Medicine and Surgery
|December 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and impact of solar lentigines: An international survey.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Patterns of regret for inadequate sun protection: A population-based study [HELIOS].

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

World vitiligo day: a model for grassroots medical activism and pharmaceutical innovation.

Frontiers in medicine·2025
Same author

Corrigendum to "The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy" [Eur. J. Pharmacol. 991 (2025) 177310].

European journal of pharmacology·2025
Same author

Attitudes and behaviors regarding sun exposure in Japan compared to Europe and North America.

The Journal of dermatology·2024
Same author

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same journal

Systemic therapy for advanced cutaneous squamous cell carcinoma.

Seminars in cutaneous medicine and surgery·2019
Same journal

Atypical Fibroxanthoma.

Seminars in cutaneous medicine and surgery·2019
Same journal

Introduction, High-Risk Skin Cancer.

Seminars in cutaneous medicine and surgery·2019
Same journal

Emerging technologies for health information in dermatology: opportunities and drawbacks of web-based searches, social media, mobile applications, and direct-to-consumer genetic testing in patient care.

Seminars in cutaneous medicine and surgery·2019
Same journal

MoleMapper: an application for crowdsourcing mole images to advance melanoma early-detection research.

Seminars in cutaneous medicine and surgery·2019
Same journal

Digital imaging applications and informatics in dermatology.

Seminars in cutaneous medicine and surgery·2019
See all related articles

Porphyrias are genetic disorders caused by enzyme deficiencies in heme biosynthesis. Advances in gene mapping now enable prenatal diagnosis and in vitro gene therapy for certain types, offering new hope for patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Dermatology

Background:

  • Porphyrias are a group of genetic disorders resulting from deficiencies in seven key enzymes of the heme biosynthetic pathway.
  • Clinical manifestations vary, with some types presenting cutaneous findings (acute or subacute phototoxicity) and others neurovisceral symptoms.
  • Hereditary coproporphyria and variegate porphyria are notable for exhibiting both cutaneous and neurovisceral features.

Purpose of the Study:

  • To review the clinical spectrum and genetic basis of porphyrias.
  • To highlight recent advancements in diagnostic and therapeutic approaches for porphyrias.
  • To discuss the implications of gene mapping for genetic counseling and treatment.

Main Methods:

  • Review of existing literature on porphyrias, focusing on enzyme deficiencies, clinical presentations, and genetic information.

Related Experiment Videos

  • Analysis of recent breakthroughs in molecular genetics, including chromosomal assignments of relevant genes.
  • Examination of case studies and research on in vitro gene therapy applications.

    • Main Results:

    • Chromosomal assignments for all genes encoding defective enzymes in the heme biosynthetic pathway have been established.
    • Prenatal diagnosis is now feasible for congenital erythropoietic porphyria.
    • Successful in vitro gene therapy has been demonstrated for congenital erythropoietic porphyria and erythropoietic protoporphyria.

    Conclusions:

    • The genetic understanding of porphyrias has significantly advanced, enabling precise diagnostics.
    • Gene therapy holds promise as a future treatment modality for specific porphyrias.
    • Continued research into the heme biosynthetic pathway and genetic disorders is crucial for improving patient outcomes.